Share Picks 2021 - Thread banned users post #1

peterofthebr · 02-02-2021 11:08PM

**
Diamonds are only made under pressure.. Diamond hands.!!!!!!!

With all this RH and others the solution is to have instant trade transactions none this T+1,T+2,T+3 jazz.. a company looking to fix this using crypto tech is...

paxos

Worth keeping an eye on.

retalivity · 02-02-2021 11:11PM

AMZN hit 100bn in sales for the last quarter, and even with Bezos stepping down, its gonna hit $3500 tomorrow

Atlantic Dawn · 02-02-2021 11:15PM

Gamma1 wrote: »

Switched from NIO to TATA. Somebody mentioned it on the thread.

Yes was me, there was a scrappage scheme announced in India yesterday which should boost sales...
https://www.reuters.com/article/india-budget-autos/india-to-proceed-soon-with-cash-for-clunkers-scheme-to-boost-car-sales-idUKL4N2K73LV

Ford is doing great too, up 23% YTD, their European lineup of cars is relatively poor at the moment but they have some EV models coming, might be also worth a look.

in2dark · 02-02-2021 11:15PM

retalivity wrote: »

AMZN hit 100bn in sales for the last quarter, and even with Bezos stepping down, its gonna hit $3500 tomorrow

Amazon without bezos will be cheaper ;-)
He has expensive "hobbies" :-)

Telo123 · 02-02-2021 11:20PM

Alphabet up over 7% after hours after earnings solid 13% return over last few days

peterofthebr · 02-02-2021 11:28PM

peterofthebr wrote: »

**
Diamonds are only made under pressure.. Diamond hands.!!!!!!!

With all this RH and others the solution is to have instant trade transactions none this T+1,T+2,T+3 jazz.. a company looking to fix this using crypto tech is...

paxos

Worth keeping an eye on.

Will due DD thanks

cronos · 02-02-2021 11:37PM

Treppen wrote: »

Trying to confirm my bias for some positive stories on PSTH Spac but there's not much love for it out there. Is it because their choice is just not going to be sexy enough?

It's still 10% of my portfolio. I'd have suggested it as a good purchase last friday when it was around 26. Not sure at 29. No leak's make it difficult to know what's going on. If he managed stripe then he's a legend and something similar to CCIV happens, if bloomberg I'd still expect gains from 29 but more similar to something like IPOE which is still very good. After that if he does something out of left field like subway it could get rough, can't see that happening though.

MuddyDog · 02-02-2021 11:45PM

Is Paxos on T212 or DeGiro? Don't see it.

daheff · 03-02-2021 12:06AM

This is it wrote: »

Yeah he was 30+ yesterday. Diamond hands

He was +48m at one stage that I saw. Down 26m since then.

Question is if that screenshot is genuine now??
I'd like to believe it is, but there's so much sh*the floating around who knows.

Jeff2 · 03-02-2021 12:25AM

daheff wrote: »

He was +48m at one stage that I saw. Down 26m since then.

Question is if that screenshot is genuine now??
I'd like to believe it is, but there's so much sh*the floating around who knows.

Got to take into account he sold $13m.

drunkmonkey · 03-02-2021 12:29AM

Any thoughts on Ford after the deal to put google in their cars?

Coneygree · 03-02-2021 12:54AM

Yeah if you go through his post history he's been posting the same style screenshot over and over again with ages, it's legit in my opinion. Although it'd be hilarious if he's been shopping his ones for the last week and actually cashed everything at the peak and is now just stringing along the idiots.

As someone said he's already cashed 13m, he's set for life. Yeah missing out on another 40 stings a lot but he's still incredibly lucky things have panned out how they have.

Banana Republic 1 · 03-02-2021 01:00AM

drunkmonkey wrote: »

Any thoughts on Ford after the deal to put google in their cars?

Google have the same deal with GM

Timing belt · 03-02-2021 01:07AM

Coneygree wrote: »

Yeah if you go through his post history he's been posting the same style screenshot over and over again with ages, it's legit in my opinion. Although it'd be hilarious if he's been shopping his ones for the last week and actually cashed everything at the peak and is now just stringing along the idiots.

As someone said he's already cashed 13m, he's set for life. Yeah missing out on another 40 stings a lot but he's still incredibly lucky things have panned out how they have.

I doubt it is the case but if a hedge fund did want to manipulate the market it would be one brilliant idea to be involved in WSB's and stir up a storm and ride the wave to the top at the expense of another hedge fund and then use the proceeds to short the stock to ride the wave back down. As I say I don't think this is the case but I would not be surprised if there was a % of traders doing so...

Fromvert · 03-02-2021 01:12AM

Coneygree wrote: »

Yeah if you go through his post history he's been posting the same style screenshot over and over again with ages, it's legit in my opinion. Although it'd be hilarious if he's been shopping his ones for the last week and actually cashed everything at the peak and is now just stringing along the idiots.

As someone said he's already cashed 13m, he's set for life. Yeah missing out on another 40 stings a lot but he's still incredibly lucky things have panned out how they have.

His name and face have been all over the media the last week. Saying you don't have $40-$50m would be the safe approach to it if he has cashed out the all of it. He probably already regrets saying he cashed out the $13m as that's a sum of money that will have every conman, crook and every friend/relative with a brass neck trying to get their hands into his pockets.

Treppen · 03-02-2021 03:07AM

I wonder if this right to repair thing takes off will iFixit become a target for a spac

manonboard · 03-02-2021 09:28AM

I think Amazon is making the right move with the CEO switch. Although bezos is fantastic for the company. The chief of AWS taking over clearly shows the direction they are intending to take imo. AWS is going to be the behemoth of amazon in time to come. The options for western companies to join the cloud is 2...maybe 3 if you include google. The have no option to join the cloud, and once in it, the monthly bills constantly increase.
As an AWS developer and cost management expert on my team, the writing is on the wall in terms of AWS profitability. Its insane how much we will keep adding to amazons monthly bill gladly given the services we get. The value is immense.

CAstudent · 03-02-2021 10:15AM

cronos wrote: »

The more it's going up the more I'm thinking it's too big to fail. They will never be able to raise funds again from retail investors anyway. SPAC's will be closed for them forever.

Does CCX give you any cause for concern? I hope you're right though as have CCIV myself!

daheff · 03-02-2021 10:23AM

Fromvert wrote: »

His name and face have been all over the media the last week. Saying you don't have $40-$50m would be the safe approach to it if he has cashed out the all of it. He probably already regrets saying he cashed out the $13m as that's a sum of money that will have every conman, crook and every friend/relative with a brass neck trying to get their hands into his pockets.

plenty of millionaires (&billionaires) over in the Us where he'll now be living. He'll be one of many they target

he'll make a ton more on podcasts, his youtube and other stocks he tips (self fulfilling prophecies then cos everybody will pile in because he tips them).

Chuckie_Egg · 03-02-2021 10:30AM

drunkmonkey wrote: »

Any thoughts on Ford after the deal to put google in their cars?

A positive for ford, but even with Google they are still the underdogs in the EV world. Google brings AI to the table but lacks any EV and is miles behind in radar, ultrasound, battery and Camera tech compared to Tesla, Nio and VW

03-02-2021 10:33AM

Sooo... Edesa

Got C$14 funding by the Canadian government yesterday. Justin Trudeau announced backing (in French) of Edesa Biotech at a press conference. And a significant write up on the official PM website. https://pm.gc.ca/en/news/news-releases/2021/02/02/new-support-produce-covid-19-vaccines-and-treatments-canada

Key Edesa points below...

Up to $14 million to Edesa Biotech Inc. (Edesa), a biopharmaceutical company based in Markham, Ontario, to advance work on a monoclonal antibody therapy for acute respiratory distress syndrome, which is the leading cause of COVID-19 deaths. Edesa’s $18.7 million project has received Health Canada approval to conduct its phase 2 clinical trials, and has begun administering its treatment to clinical trial participants in Canada.

Edesa Biotech Inc. is a biopharmaceutical company founded by experts in the fields of inflammation and infectious diseases. It has a strong record in biologics, and has demonstrated success in its ongoing clinical development programs. Its project proposal was reviewed by the COVID-19 Therapeutics Task Force.
Today’s investment will help Edesa advance its monoclonal antibody therapy (EB05). In addition to its potential to treat acute respiratory distress syndrome and mitigate inflammation complications in COVID-19, Edesa’s therapy has the potential to also treat other pathogens known to cause pandemics, such as influenza.

The share price spiked yesterday to only $8.15 before profit taking drove it down into the red for the day (crazy stock). But the news of the JT press conference and web page didn't become very public until after hours. Hence the rise, and current ask at $7.20 (current price $6). I think this is crazy undervalued considering what revenues remdesivir brings.

IF I sound like a one trick pony, I've been pretty much all in on and adding since July 2020. Yeah, I know, but what if...

cronos · 03-02-2021 10:42AM

Deleted User wrote: »

Sooo... Edesa

Got C$14 funding by the Canadian government yesterday. Justin Trudeau announced backing (in French) of Edesa Biotech at a press conference. And a significant write up on the official PM website. https://pm.gc.ca/en/news/news-releases/2021/02/02/new-support-produce-covid-19-vaccines-and-treatments-canada

Key Edesa points below...

Up to $14 million to Edesa Biotech Inc. (Edesa), a biopharmaceutical company based in Markham, Ontario, to advance work on a monoclonal antibody therapy for acute respiratory distress syndrome, which is the leading cause of COVID-19 deaths. Edesa’s $18.7 million project has received Health Canada approval to conduct its phase 2 clinical trials, and has begun administering its treatment to clinical trial participants in Canada.

Edesa Biotech Inc. is a biopharmaceutical company founded by experts in the fields of inflammation and infectious diseases. It has a strong record in biologics, and has demonstrated success in its ongoing clinical development programs. Its project proposal was reviewed by the COVID-19 Therapeutics Task Force.
Today’s investment will help Edesa advance its monoclonal antibody therapy (EB05). In addition to its potential to treat acute respiratory distress syndrome and mitigate inflammation complications in COVID-19, Edesa’s therapy has the potential to also treat other pathogens known to cause pandemics, such as influenza.

The share price spiked yesterday to only $8.15 before profit taking drove it down into the red for the day (crazy stock). But the news of the JT press conference and web page didn't become very public until after hours. Hence the rise, and current ask at $7.20 (current price $6). I think this is crazy undervalued considering what revenues remdesivir brings.

IF I sound like a one trick pony, I've been pretty much all in on and adding since July 2020. Yeah, I know, but what if...

If it hit's $5 again I'll definitely throw a few quid at it. Added to my watch list.

cc87 · 03-02-2021 10:42AM

Good start to the day...

4d pharma finally starting to rise in anticipation of NASDAQ listing.
UWMC up 7% pre-market before their earnings report at end of market today

Both have been in the red for me for a while now!

03-02-2021 10:43AM

cronos wrote: »

If it hit's $5 again I'll definitely throw a few quid at it. Added to my watch list.

Hopefully next hits $5 after the stock split

Otherwise if you hear the sobs of a grown man, that'll be me :pac:

cronos · 03-02-2021 10:46AM

CAstudent wrote: »

Does CCX give you any cause for concern? I hope you're right though as have CCIV myself!

How do you mean concern? CCX just does not have an attractive target in Skillsoft. While most people who have worked in a corporation have probably done a Skillsoft course, it's low value courses and was very basic. It's probably been 10 years since I've used the software though, they could have dramatically improved. They also have a strong customer base so are already in the door with many companies. Hard to predict. I think if you are buying that you really have to be in it for the long term, in which case it's hard to know if it's better to just wait till after the merger. CCIV is a different animal and it's either deal and big or no deal and collapse. I rate deal significantly higher myself, but you never know...

Nemeses2050 · 03-02-2021 10:46AM

4D starts on a high note, but it peters out as the day progress...that's been the norm last few weeks.

YFlyer · 03-02-2021 10:47AM

How about Zoom? Has it reach peak during the Covid situation or is it just the beginning?

cronos · 03-02-2021 10:47AM

Deleted User wrote: »

Hopefully next hits $5 after the stock split Otherwise if you hear the sobs of a grown man, that'll be me :pac:

Hearing sob's is the perfect time to buy most things as long as it has the potential to recover

good for everyone.

Keep us in the loop on major price decreases anyway.

AmberGold · 03-02-2021 10:55AM

Deleted User wrote: »

The share price spiked yesterday to only $8.15 before profit taking drove it down into the red for the day (crazy stock). But the news of the JT press conference and web page didn't become very public until after hours. Hence the rise, and current ask at $7.20 (current price $6). I think this is crazy undervalued considering what revenues remdesivir brings.

IF I sound like a one trick pony, I've been pretty much all in on and adding since July 2020. Yeah, I know, but what if...

Holding 1000 shares myself for the same time-frame, being all in on Edesa must be tough given the lack of much anticipated news. Can't see $14M of funding moving the needle much.

03-02-2021 10:59AM

AmberGold wrote: »

Holding 1000 shares myself for the same time-frame, being all in on Edesa must be tough given the lack of much anticipated news. Can't see $14M of funding moving the needle much.

More so the criteria behind it, evidence based independent testing that gave the funding the green light. The phase two trials cost $18, so the Canadian government gave as much as they probably could without actually funding all of it, which they possibly can't/wont do.

So, it's not the actual funding but, that it was given at all.

Share Picks 2021 - Thread banned users post #1

Comments